News

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...
Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...
Doctors are continuing to issue warnings regarding the illicit use of Ozempic, Wegovy and Mounjaro as weight loss injections, ...
Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...
The FDA launched a generative artificial intelligence tool designed to help employees, such as scientific reviewers and ...
New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among ...
Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Doctors have warned users of medicines such as Ozempic Wegovy and Mounjaro about an irreversible potential side effect ...
Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...